|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vishal M, Swetha R, Thejaswini G, Arumugam
B and Selvamurugan N: Role of Runx2 in breast cancer-mediated bone
metastasis. Int J Biol Macromol. 99:608–614. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu S, Kong D, Chen Q, Ping Y and Pang D:
Oncogenic long noncoding RNA landscape in breast cancer. Mol
Cancer. 16:1292017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo T, Yan Y, He Q, Ma X and Wang W:
miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by
targeting RAGE. Oncol Rep. 39:2906–2914. 2018.PubMed/NCBI
|
|
5
|
Zhou Y, Meng X, Chen S, Li W, Li D, Singer
R and Gu W: IMP1 regulates UCA1-mediated cell invasion through
facilitating UCA1 decay and decreasing the sponge effect of UCA1
for miR-122-5p. Breast Cancer Res. 20:322018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17:612018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taylor DH, Chu ET, Spektor R and Soloway
PD: Long non-coding RNA regulation of reproduction and development.
Mol Reprod Dev. 82:932–956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C,
Wang J, Tan Q, Cheng Y, Xia E, et al: C-MYC-induced upregulation of
lncRNA SNHG12 regulates cell proliferation, apoptosis and migration
in triple-negative breast cancer. Am J Transl Res. 9:533–545.
2017.PubMed/NCBI
|
|
9
|
Guan YX, Zhang ZM, Chen XZ, Zhang Q, Liu
SZ and Zhang YL: Lnc RNA SNHG20 participated in proliferation,
invasion and migration of breast cancer cells via miR-495. J Cell
Biochem. 119:7971–7981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Zhai L, Wang H, Liu C, Zhang J, Chen
W and Wei Q: Downregulation of LncRNA GAS5 causes trastuzumab
resistance in breast cancer. Oncotarget. 7:27778–27786.
2016.PubMed/NCBI
|
|
12
|
Chung S, Nakagawa H, Uemura M, Piao L,
Ashikawa K, Hosono N, Takata R, Akamatsu S, Kawaguchi T, Morizono
T, et al: Association of a novel long non-coding RNA in 8q24 with
prostate cancer susceptibility. Cancer Sci. 102:245–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Sun R, Liang Y, Pan X, Li Z, Bai P,
Zeng X, Zhang D, Zhang L and Gao L: Association between
polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of
colorectal cancer. J Exp Clin Cancer Res. 32:1042013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pestell RG and Yu Z: Long and noncoding
RNAs (lnc-RNAs) determine androgen receptor dependent gene
expression in prostate cancer growth in vivo. Asian J Androl.
16:268–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang L, Qiu M, Xu Y, Wang J, Zheng Y, Li
M, Xu L and Yin R: Upregulation of long non-coding RNA PRNCR1 in
colorectal cancer promotes cell proliferation and cell cycle
progression. Oncol Rep. 35:318–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng D, Bao C, Zhang X, Lin X, Huang H
and Zhao L: LncRNA PRNCR1 interacts with HEY2 to abolish
miR-448-mediated growth inhibition in non-small cell lung cancer.
Biomed Pharmacother. 107:1540–1547. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong ZM, Tang ZY and Sun XL: LncRNA PRNCR1
regulates CXCR4 expression to affect osteogenic differentiation and
contribute to osteolysis after hip replacement. Gene. 673:251–261.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiao S, Wang SY and Huang Y: LncRNA PRNCR1
promoted the progression of eclampsia by regulating the MAPK signal
pathway. Eur Rev Med Pharmacol Sci. 22:3635–3642. 2018.PubMed/NCBI
|
|
19
|
Liu MC, Pitcher BN, Mardis ER, Davies SR,
Friedman PN, Snider JE, Vickery TL, Reed JP, DeSchryver K, Singh B,
et al: PAM50 gene signatures and breast cancer prognosis with
adjuvant anthracycline- and taxane-based chemotherapy: Correlative
analysis of C9741 (Alliance). NPJ Breast Cancer. 2:e150232016.
View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun W, Li AQ, Zhou P, Jiang YZ, Jin X, Liu
YR, Guo YJ, Yang WT, Shao ZM and Xu XE: DSCAM-AS1 regulates the
G1/S cell cycle transition and is an independent prognostic factor
of poor survival in luminal breast cancer patients treated with
endocrine therapy. Cancer Med. 7:6137–6146. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu X, Ding D, Zhang J and Cui J: Knockdown
lncRNA HOTAIR sensitize breast cancer cells to ionizing radiation
through activating miR-218. Biosci Rep. 39:BSR201810382019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiao E, Chen D, Li Q, Feng W, Yu X, Zhang
X, Xia L, Jin J and Yang H: Long noncoding RNA TALNEC2 plays an
oncogenic role in breast cancer by binding to EZH2 to target
p57(KIP2) and involving in p-p38 MAPK and NF-κB pathways. J Cell
Biochem. 120:3978–3988. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith BN and Bhowmick NA: Role of EMT in
metastasis and therapy resistance. J Clin Med. 5:E172016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia XL, Xue D, Xiang TH, Xu HY, Song DK,
Cheng PG and Wang JQ: Overexpression of long non-coding RNA CRNDE
facilitates epithelial-mesenchymal transition and correlates with
poor prognosis in intrahepatic cholangiocarcinoma. Oncol Lett.
15:4105–4112. 2018.PubMed/NCBI
|
